Athira Pharma, Inc.
ATHA
$3.87
-$0.08-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 11.54% | -30.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.72% | -23.54% | |||
| Operating Income | 5.72% | 23.54% | |||
| Income Before Tax | 5.10% | 23.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.10% | 23.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.10% | 23.81% | |||
| EBIT | 5.72% | 23.54% | |||
| EBITDA | 5.92% | 24.16% | |||
| EPS Basic | 5.93% | 23.91% | |||
| Normalized Basic EPS | 5.93% | 24.44% | |||
| EPS Diluted | 5.93% | 23.91% | |||
| Normalized Diluted EPS | 5.93% | 24.44% | |||
| Average Basic Shares Outstanding | 0.89% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.89% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||